The TaMADOR consortium hosted a successful evening workshop at the 2026 US HUPO Conference in St. Louis, Missouri.

Workshop: Targeting Diabetes and Obesity: MS-based Assays that Inform Clinical Research Transferability

The workshop brought together experts from across the consortium to present advances in mass spectrometry-based assays relevant to diabetes and obesity research, with a focus on clinical research transferability.

The workshop featured three presentations:

  • Lorenz Nieves, PNNL
    • Interlaboratory validation of a glucagon and oxyntomodulin immuno-MRM workflow
  • Jun Qu, University of Buffalo
    • An Antibody Cocktail–Based Immunoaffinity–LC–MS Method for Ultra-Sensitive and Robust Quantification of Circulating Proinsulin Forms and C-peptide
  • Michael MacCoss, University of Washington
    • Using mass spectrometry to measure patient response to therapy

View the conference agenda